Working with “living therapies” during COVID-19 has changed access, resource planning and management in CGT trials.
-
Date Time 10:00 - 11:30
Location Webinar Timezone America/New York
Overview
This ICON sponsored webinar program explores the bioethics of clinical trials at Preclinical and Phase 1 stages. An in-depth look at the unique nuances of cell and gene therapy (CGT) trials and how to keep them on track during COVID-19 will follow. The expert panel will conclude with a discussion on strategies for patient advocacy within this changed environment.
Register for the upcoming webinar to learn:
- What is the ethical protocol of approaching patients for early-stage clinical trials?
- What are the key differences between CGT clinical trials and traditional models?
- How has COVID-19 changed accessibility, resource planning and management of CGT trials?
- How has patient advocacy and support changed in the face of a global pandemic?
On-demand webinar archive
To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.
Presenters
![](https://icon.widen.net/content/025c8531-c348-4613-b347-cbc53336a459/web/Joeckel_Tamie_10.png?crop=yes&w=240&h=240&itok=8qU9-h-U)
Tamie Joeckel
![](https://icon.widen.net/content/9ae9f8c2-8337-44de-958b-cb3ebda93f52/web/steve.jpg?crop=yes&w=240&h=240&itok=Ff7IlfDZ)
Steven Devine, MD, PhD
![](https://icon.widen.net/content/530db296-a992-4f6a-a6a9-50a0f3621b99/web/Julie_Walters.png?crop=yes&w=240&h=240&itok=3XTarQzW)
Julie Walters
Mark Yarborough, PhD
This webinar is sponsored by ICON in collaboration with the ISCT Market Access & Patient Advocacy (MAPA) Commercialization Subcommittee.